Klyubin I - Search Results

1

Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites.

Freir DB, Nicoll AJ, Klyubin I, Panico S, Mc Donald JM, Risse E, Asante EA, Farrow MA, Sessions RB, Saibil HR, Clarke AR, Rowan MJ, Walsh DM, Collinge J. Freir DB, et al. Among authors: klyubin i. Nat Commun. 2011 Jun 7;2:336. doi: 10.1038/ncomms1341. Nat Commun. 2011. PMID: 21654636 Free PMC article.

2

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.

Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ. Walsh DM, et al. Among authors: klyubin i. Nature. 2002 Apr 4;416(6880):535-9. doi: 10.1038/416535a. Nature. 2002. PMID: 11932745

3

Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition.

Walsh DM, Klyubin I, Fadeeva JV, Rowan MJ, Selkoe DJ. Walsh DM, et al. Among authors: klyubin i. Biochem Soc Trans. 2002 Aug;30(4):552-7. doi: 10.1042/bst0300552. Biochem Soc Trans. 2002. PMID: 12196135 Review.

4

Synaptic plasticity in animal models of early Alzheimer's disease.

Rowan MJ, Klyubin I, Cullen WK, Anwyl R. Rowan MJ, et al. Among authors: klyubin i. Philos Trans R Soc Lond B Biol Sci. 2003 Apr 29;358(1432):821-8. doi: 10.1098/rstb.2002.1240. Philos Trans R Soc Lond B Biol Sci. 2003. PMID: 12740129 Free PMC article. Review.

5

Soluble Arctic amyloid beta protein inhibits hippocampal long-term potentiation in vivo.

Klyubin I, Walsh DM, Cullen WK, Fadeeva JV, Anwyl R, Selkoe DJ, Rowan MJ. Klyubin I, et al. Eur J Neurosci. 2004 May;19(10):2839-46. doi: 10.1111/j.1460-9568.2004.03389.x. Eur J Neurosci. 2004. PMID: 15147317

6

Mechanisms of the inhibitory effects of amyloid beta-protein on synaptic plasticity.

Rowan MJ, Klyubin I, Wang Q, Anwyl R. Rowan MJ, et al. Among authors: klyubin i. Exp Gerontol. 2004 Nov-Dec;39(11-12):1661-7. doi: 10.1016/j.exger.2004.06.020. Exp Gerontol. 2004. PMID: 15582282

7

Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo.

Klyubin I, Walsh DM, Lemere CA, Cullen WK, Shankar GM, Betts V, Spooner ET, Jiang L, Anwyl R, Selkoe DJ, Rowan MJ. Klyubin I, et al. Nat Med. 2005 May;11(5):556-61. doi: 10.1038/nm1234. Epub 2005 Apr 17. Nat Med. 2005. PMID: 15834427

8

Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.

Rowan MJ, Klyubin I, Wang Q, Anwyl R. Rowan MJ, et al. Among authors: klyubin i. Biochem Soc Trans. 2005 Aug;33(Pt 4):563-7. doi: 10.1042/BST0330563. Biochem Soc Trans. 2005. PMID: 16042545 Review.

9

The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention.

Walsh DM, Klyubin I, Shankar GM, Townsend M, Fadeeva JV, Betts V, Podlisny MB, Cleary JP, Ashe KH, Rowan MJ, Selkoe DJ. Walsh DM, et al. Among authors: klyubin i. Biochem Soc Trans. 2005 Nov;33(Pt 5):1087-90. doi: 10.1042/BST20051087. Biochem Soc Trans. 2005. PMID: 16246051 Review.

10

Alpha v integrins mediate beta-amyloid induced inhibition of long-term potentiation.

Wang Q, Klyubin I, Wright S, Griswold-Prenner I, Rowan MJ, Anwyl R. Wang Q, et al. Among authors: klyubin i. Neurobiol Aging. 2008 Oct;29(10):1485-93. doi: 10.1016/j.neurobiolaging.2007.03.018. Epub 2007 Apr 17. Neurobiol Aging. 2008. PMID: 17442458

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters